First, this proves that investment in drug discovery for all pandemic potential viruses, fueled by basic science research, needs to be a huge priority going forward. Imagine having antivirals on the shelf for the Coronas, Avian influenza, Nipah, Ebola, etc. to stop pandemics before they started.

Secondly, I’m a little curious whether if we’d ideally administer Paxlovid in double- or triple-therapy, like we do for HIV and Hepatitis C, if we had the option. Will resistance arise to it in the next 12 - 24 months? Would love to be assuaged of my fear here.